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The Huggins Test for Cancer and Related 
Protein Determination 
By HJALMER v. PETERSON AND HAROLD w. MORGAN 
Due to the tremendous amount of research work being done on 
cancer in recent years, a number of diagnostic tests have been 
developed by different groups of individuals. One of the most 
promising of the cancer detection methods utilizes the principle of 
( 1) selective differentiation of blood sera by means of transmitted 
filtered ultra violet light. Cancer sera transmit more light and 
more fluorescence than normal or non-malignant sera, and the 
fluorescence in cancer sera appears blue or violet; in non-malignant 
sera the fluorescence is yellow or olive green. In 1800 sera, of 
which 1600 were non-malignant, the percentage of false negatives 
was about 14 per cent and the percentage of false positives was 4%. 
Another test (2) is an easy one in which drops of blood from a 
finger puncture are allowed to dry on a glass slide and viewed. 
Non-malignant blood produces a dark mass centrally located in the 
dried drop, whereas cancerous blood produces no centrally located 
mass. Under the microscope non-malignant blood produces rouleau 
formation with no variation in the size or shape of the red blood 
corpuscles. Malignant blood produces no rouleau formation ; the 
red blood cells are arranged in a disorderly fashion, abnormal in 
size, shape, and arrangement. This test gave 96.5% correct results. 
(3) A third test is the plasma methylene blue reducing time tech-
nique. One ml. of plasma (or serum) is placed in a Wasserman 
tube and 0.2 ml. of specially standardized methylene blue solution 
(0.15 per cent in distilled water) is added. After these are mixed, 
the tubes are immersed in boiling water. A positive malignancy is 
indicated if the methylene blue is not reduced in 10~ minutes. The 
methylene blue reduction test is coupled with a heat turbidity index 
test in which a ml. of plasma is placed in a photoelectric colorimeter 
cuvette, diluted with 5 ml. of distilled water, mixed and the trans-
mittancy read on the colorimeter. Theil the tube is immersed in 
. boiling water for 10 seconds, cooled rapidly and a second trans-
mittancy reading is taken. The difference between the two readings 
is called the coagulation of turbidity value. The colorimeter is 
standardized by using known malignant and non-malignant plasma 
samples. In the use of these tests 89% of 468 malignant cases were 
diagnosed correctly by either or both of the tests. 
The last diagnostic test of note and the one on which this dis-
cussion will center is the ( 4) Thermal Coagulation of Serum Pro-
215 
1
Peterson and Morgan: The Huggins Test for Cancer and Related Protein Determination
Published by UNI ScholarWorks,
216 IOWA ACADEMY OF SCIENCE [Vol. 57 
tein test, or the so-called "Huggins Test," as developed by Huggins, 
Miller and Jensen, of the University of Chicago. They demonstrated 
that serum from cancer patients coagulated less readily than serum 
from healthy individuals when heated in boiling water for 30 
minutes. This difference in serum from cancer patients was more 
accurately detected by the addition of iodoacetic acid which acted 
as an inhibitor to coagulation at a pH of 7.4. 
The mechanism of the inhibition of clot formation is unknown, 
but it is thought that the iodoacetic acid reacts with these molecular 
linkages in the protein which are essential to the formation of the 
clot. 
Eventually the investigators developed what they called the 
iodoacetate index which is a mathematical expression relating the 
inhibition of clotting by iodoacetic acid to the quantity of protein 
present in the serum and thus to the total number of linkages in the 
protein essential to coagulation. More specifically, the iodoacetate 
index is the micro-moles of iodoacetic acid required to inhibit 
coagulation of 1 milliliter of serum, divided by the total protein in 
grams per cent. 
The work that is about to be described was undertaken to deter-
mine the reliability of the Huggins test as a possible test for early 
cancer in individuals. It was hoped that, if the test proved reliable, 
it could be set up as a routine screening procedure for testing of 
large numbers of individuals for cancer and thus identify malignancy 
in its early stages so that effective treatment could be administered. 
PROCEDURE 
Reagents for Iodoacetic Acid Coagulation: 
1. M/15 phosphate buffer, pH 7.4,-made by dissolving 1.743 gm. 
potassium dihydrogen phosphate, KH2P041 and 7.652 gm. of 
anhydrous disodium hydrogen phosphate, Na2HP04 , in water 
and diluting to a liter. 
2. Normal Sodium hydroxide. 
3. 0.1 % phenol sulfone phthalein. 
4. 0.06 M iodoacetic acid-made by dissolving 0.279 gm. recry-
stallized iodoacetic acid in 10 ml. of M/15 phosphate buffer to 
which 2 drops of the 0.1 % phenolsulfonephthalein has been 
added. To this is added enough normal sodium hydroxide, drop 
to drop, to match the indicator color produced in 10 ml. of the 
buffer solution alone. After matching, enough additional buffer 
solution is added to make 25 ml. This solution is freshly pre-
pared each day. 
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5. 3M Sodium chloride. 
Reagents of S eru111 Protein Determinations: 
A. For micro-Kjeldahl determination: 
1. 0.01 N hydrochloric acid. 
2. 30% sodium hydroxide. 
3. Mixed indicator - made up by mixing 10 parts of 0.1 % brom-
cresol green in 95% ethanol and 2 parts of 0.1 % methyl red in 
95% ethanol in a bottle provided with a dropper drawn out to 
a fine capillary (0.05 ml. per 4 drops.) 
4. Copper sulfate - potassium sulfate mixture: 3 parts by weight 
of copper sulfate pentahydrate, CuS04 • 5H20 and one part by 
weight of potassium sulfate, K 2S041 thoroughly mixed and 
ground in a mortar. 
5. Selenium oxychloride. 
6. 2% boric acid. 
B. For Copper Sulfate-Specific Gravity method. 
1. Saturated Copper Sulfate Solution at 23°C. 
2. Stock Copper Sulfate Solution of Specific Gravity 1.100 made 
by diluting 466 ml. of saturated solution to 1 liter. 
3. Standard Copper Sulfate Solutions of Known Specific Gravities 
between 1.018 and 1.030 specific gravities at intervals of 0.002-
prepared by measuring into a 100 ml. volumetric flask a volume 
of stock solution less by 1 ml. than the value represented by the 
second and third decimal places of the desired specific gravity 
·and diluting the contents to 100 ml. These solutions were then 
placed in 4 ounce bottles, labeled with the measured specific 
gravities and tightly stoppered. 
Determination of Serum Protein Content: 
A. Micro-Kjeldahl method: (5) 
A 2-5 mg. sample of serum was weighed to the nearest 0.1 mg. 
into a porcelain microboat and the serum and boat were placed 
into a large hard glass pyrex tube (25 x 200 mm.) which 
served as a digestion flask. Three mg. of selenium oxychloride 
and 5 mg. of the copper sulfate-potassium sulfate mixture were 
added to the digestion flask, followed by 1 ml. of concentrated 
sulfuric acid. The mixture was then digested over a micro-
burner flame until the mixture cleared. After the tube was 
cool, 2 ml. of distilled water were added to the digested sample ; 
3
Peterson and Morgan: The Huggins Test for Cancer and Related Protein Determination
Published by UNI ScholarWorks,
218 IOWA ACADEMY OF SCIENCE [Vol. 57 
after three or four minutes about 8 ml. of 30% sodium hydrox-
ide were added and the tube was placed into a micro-Kjeldahl 
distillation apparatus. Four drops of the mixed indicator were 
added to 5 ml. of 2% boric acid in a SO ml. Erlenmeyer flask 
which acted as the receiver. The tip of the condenser was 
placed in the boric acid, and distillation with steam was started. 
A color change of from bluish purple to blue green indicated 
that the distillation was operating efficiently as soon as the 
ammonia from the distillation came into contact with the boric 
acid. About a minute after the first color change, the receiver 
was lowered so that the condenser tip was about 1 cm above 
the liquid and the distillation allowed to continue for about 
another minute, after which the tip was washed with a little dis-
tilled water. Titration with the 0.01 N hydrochloric acid was 
then carried out - the end point being a disappearance of the 
blue color of the indicator. The protein content was estimated 
by multiplying the total nitrogen content minus the non-protein 
nitrogen content (determined separately) by 6.25. 
B. The Copper Sulfate-Specific Gravity method: (6) 
(After running many micro-K jeldahl protein determinations 
we soon discovered that the method was time consuming. If 
the Huggins test were going to be run in large numbers, a 
shorter, reliable test for proteins should be developed. The 
copper sulfate-specific gravity method was tried and found to 
give fairly consistent protein results in comparison with the 
micro-Kjeldahl technique.) 
In this method, serum was drawn into an eye dropper with 
a drawn out tip, and a small drop was allowed to fall by gravity 
from a height of about 1 cm. above the solution into one of the 
standard copper solutions of known specific gravity. The be-
havior of the drop \vas closely observed for about 10 seconds 
after it had lost the momentum of its fall. If the drop rose 
during the 10 second period, it was lighter than the test solu-
tion; if it continued to fall, it was heavier; if it remained sta-
tionary, it had the same specific gravity as the solution. If the 
specific gravity of the drop was not ascertained by the first 
test, the procedure was repeated on solutions of higher or lower 
specific gravity until a solution was found in which the drop 
remained stationary, which gave the specific gravity of the 
serum, or there were two adjacent standards, in one of which 
the drop rose and in the other it fell. In this case interpolation 
between the values of the two standards was made. From the 
4
Proceedings of the Iowa Academy of Science, Vol. 57 [], No. 1, Art. 24
https://scholarworks.uni.edu/pias/vol57/iss1/24
1950] HUGGINS TEST FOR CANCER 219 
determined specific gravity, results were obtained by reference 
to the line chart accompanying the description of the method. 
Table 1 shows our results as to the comparison of serum 
protein values when analyzed by the two different methods of 
determination. 
Table I 
Comparison of Micro-Kjeldahl and Copper Sulfate-Specific Gravity 
Serum Protein Determinations in Grams Per Cent 
Case Number 
105 
106 
107 
108 
109 
111 
115 
120 
124 
126 
127 
131 
Micro-Kjeldahl Method 
6.71 
7.12 
6.09 
6.66 
6.59 
7.15 
6.73 
6.93 
7.08 
6.73 
6.51 
7.18 
Copper Sulfate Method 
6.70 
7.12 
5.90 
6.60 
6.70 
7.12 
6.70 
6.95 
7.12 
6.93 
6.62 
7.10 
The average difference between the results of the two meth-
ods on 27 different sera, including those listed above, was 0.07 
grams percent. No clinically significant change in the results 
of the Huggins test was evidenced by this small difference in 
the protein values. 
After learning that the two methods gave close results, we 
decided that the copper sulfate-specific gravity method of serum 
protein determination would be used for all subsequent Huggins 
tests. If, in the final calculation, it was found that a blood could 
be either positive or negative for cancer by a slight variation in 
the serum protein determination, then a micro-Kjeldahl deter-
mination would be run and its result used in the calculation. 
Determination of Iodoacetic Acid Index: 
The reagents, the tube set up, and the method and equip-
ment used to determine the iodoacetate index, were exactly the 
same as used. by the authors of the method. The preparation 
of the necessary reagents for the determination was described 
earlier in this report. The arrangement of the tubes, volumes 
of the various reagents and the final concentration of the 
iodoacetic acid in each tube are found in the following table : 
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Table 2 
Tube No. 2 3 4 s 6 7 8 9 10 
Serum, ml. 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 
Sodium Chloride, 
3M, ml. .12 .12 .12 .I2 .12 .I2 .12 .12 .I2 .I2 
Buffer, ml. .23 .20 .I8 .IS .I3 .10 .08 .OS .03 .00 
Iodoacetic Acid, ml. .IS .I8 .20 .23 .2S .28 .30 .33 .3S .38 
Concentration of 
Iodoacetic Acid uM 9.0 10.8 I2.0 I3.8 IS.O I6.8 I8.0 19.8 21.0 22.8 
After the tubes were removed from the boiling water, by 
the authors' definition, serum was coagulated when it was thor-
oughly solid and would not pour when it was inverted and 
gently rotated. The end point was the concentration of the 
iodoacetic acid in the last tube in the series which showed 
coagulation. This tube's iodoacetic acid concentration multi-
plied by four and divided by the protein content of the serum 
in grams per cent gave the iodoacetate index of the serum. 
(The authors later developed a different technique (7) for 
determining the end point. A fine wire loop of stiff wire -
no. 8, piano wire - was made to fit closely the inside of the 
tubes. This was thrust to the bottom of the tubes and with-
drawn. The tubes were then inverted to a 45 degree angle. If 
the contents of a tube remained in the end of the tube or slid 
down the tube as a well defined mass, the tube was read 
"coagulated.") 
In their original work, the investigators chose the iodoacetate 
index of 9.00 as the dividing line between positive and negative 
tests for cancer because that number excluded all tests run on 
healthy persons in the first series of 283 tests, in which there were 
16 patients with non-malignant pathology, 85 patients with cancer, 
and the remainder healthy individuals. All tests run on cancer 
patients gave results for the index below 9.00; all healthy individ-
uals gave results above 9.00. For this reason we chose the iodoacetic 
acid index of 9.00 as the dividing line between positive and negative 
cancer tests. 
Results: 
Out of 31 known cases of cancer, 24 had iodoacetate indices 
of less than 9.00. Thus, using 9.00 as the dividing line between 
positive and negative tests for cancer, correct results were ob-
tained in 77.4% of the cases. 
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Out of 42 non-malignant cases tested, 24 had indices of less 
than 9.00. (Many of these cases and the diagnosis are listed 
in Table III. The correct diagnosis was not obtainable on the 
remainder.) 
Most of the normal cases in Table III came from the Mason 
City, Iowa, Blood Bank, and we assumed that the individuals 
donating blood were free from cancer. Out of 170 normal 
cases, 3 had iodoacetate indices of less than 9.00. There was 
no possibility of checking the three individuals for possible 
cancer symptoms. 
Case No. 
8 
14 
16 
23 
70 
81 
lll 
208 
233 
243 
244 
245 
246 
249 
250 
251 
Table 3 
Iodoacetate Index and Diagnosis of Patients 
with Noncancerous Diseases. 
Diagnosis Iodoacetate Index 
Acute appendix 6.52 
Gall bladder infection 7.09 
Ulcerative prostatitis 6.59 
Arteriosclerotic occlusive 6.43 
Lung tuberculosis 6.35 
Acute appendix 8.98 
Cervicitis 8.42 
Fibroids 8.50 
Abdominal hysterectomy 7.74 
3rd degree burn 6.86 
Multiple fractures 6.17 
Fracture of os calsis 8.13 
Fracture of tibia 7.20 
Hemorrhoids 8.24 
Acute pancreatitis 7.00 
Ruptured L-5 disc 8.69 
SUMMARY 
The thermal coagulation of serum protein test, so-called Huggins 
Test, was run on 243 individuals. Thirty-one of these individuals 
had proven cancer; 42 had non-malignant pathology; and 170 
were presumably normal individuals. 
It was found (a) that correct results were obtained in 77.4 per 
cent of the cases with proven cancer, (b) that 57.3 per cent of the 
test run on noncancerous patients gave iodoacetate index results 
that were lower than 9.00 and thus would be in the cancerous 
range, ( c) that three individuals out of 170 apparently normal 
individuals had iodoacetate indices lower than 9.00 - about 1.8% 
of the total. 
On the basis of this data it is logical to assume that the thermal 
coagulation test is not specific enough for cancer and therefore 
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Iodoacetate Index 
Distribution of iodoacetate indices in normal, healthy individuals; non-malignant cases 
with no proven cancer; and patients with cancer. 
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would not be satisfactory as a screen test for early cancer m 
individuals. 
For most clinical purposes, the copper sulfate-specific gravity 
method of determining serum proteins is satisfactory, inasmuch as 
its results are very close to the results obtained from micro-Kjeldahl 
determinations. 
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